SCHEMBL7604874

SCHEMBL7604874

COCc1c(O)ccc(C)c1S(=O)(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.36
SRC P12931 1/20 0.36
AXL P30530 1/20 0.36
PTK2 Q05397 1/20 0.36
AURKB Q96GD4 1/20 0.36
ALK Q9UM73 1/20 0.36
HPGD P15428 3/20 0.34
HSD17B10 Q99714 3/20 0.34
LMNA P02545 2/20 0.34
HIF1A Q16665 1/20 0.34
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
PKM P14618 1/20 0.33
RECQL P46063 2/20 0.32
POLB P06746 1/20 0.32
ESR2 Q92731 1/20 0.32
TP53 P04637 1/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
NT5E P21589 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872699 0.84 ALDH1A1 (0.34) HPGDHSD17B10LMNAALDH1A1GAA
SCHEMBL10650084 0.84 LMNA (0.36) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL4208635 0.81 ESR1 (0.39) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL10618792 0.79 HPGD (0.33) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL9028592 0.78 NR3C1 (0.32)
SCHEMBL9029091 0.78 NR3C1 (0.32)
SCHEMBL8443514 0.77 HPGD (0.41) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL8624118 0.75 PTGS2 (0.31) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL1838149 0.75 SRD5A1 (0.41) HPGDHSD17B10LMNAHIF1AALDH1A1
SCHEMBL900006 0.75 KMT2A (0.35) HPGDHSD17B10LMNAHIF1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed
EP-0435152-B1 Process for the enantioselective preparation of (omega-1)-hydroxyalkylxanthines HOECHST AG (DE) 1996-11-13 EP disclosed
EP-0435152-A2 Process for the enantioselective preparation of (omega-1)-hydroxyalkylxanthines HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 EP disclosed